Cal-Maine Foods is a dominant industry player with strong moats, scale, and a robust balance sheet but faces significant earnings cyclicality. CALM benefits from its low-cost position, recent acquisitions, and product mix improvements, especially the secular growth in specialty eggs. Valuation assumes a mid-cycle scenario: ~$3.5B revenue, 8–10% net margin, and an earnings yield of 7–9%, with upside from internal initiatives.
A year-long bipartisan investigation revealed that three of the US's top egg producers "secretly communicated" with each other to inflate the daily egg price index between June 2022 and March 2025.
Cal-Maine Foods offers pure-play exposure to egg prices via a dominant, financially disciplined, and debt-free operator with a resilient variable dividend structure. CALM's revenues and scale have trended upward despite commodity volatility, aided by strategic acquisitions and recent expansion into value-added products. The stock trades slightly above book value with over $1B in cash, reflecting market confidence even as egg prices hit decade lows and earnings compress.
Cal-Maine Foods faces a cyclical downturn with egg prices at 10-year lows, compressing margins and near-term earnings. CALM maintains a debt-free balance sheet and $1.1B in net cash, enabling opportunistic buybacks and strategic M&A during industry weakness. Management is shifting toward specialty eggs, now 50% of sales, supporting structurally stronger margins and more stable demand.
Shares of Cal-Maine Foods fell in extended trading Friday after a report that the Justice Department could be close to filing a civil antitrust lawsuit against the major egg producer and some of its rivals.
Cal-Maine Foods is positioned as a buy despite weak results from low egg prices, with specialty eggs and prepared foods stabilizing revenue. CALM's recent $128.5M Creighton Brothers acquisition and ongoing buybacks are not fully priced in, enhancing forward value. The company's variable dividend policy and strong balance sheet (no long-term debt, $1.15B cash) support capital flexibility and shareholder returns.
Cal-Maine Foods, Inc. (CALM) Q3 2026 Earnings Call Transcript
Cal-Maine Foods logged lower profit and sales in its fiscal third quarter, hurt by materially lower egg prices compared with historic levels seen in the prior year.
Cal-Maine Foods remains a core defensive holding, benefiting from disciplined owner management and a debt-free, cash-rich balance sheet. CALM's recent $128.5M acquisition of Creighton Brothers and Crystal Lake expands production capacity, geographic reach, and value-added prepared foods exposure. Specialty eggs and prepared foods now comprise 46% of net sales, with prepared foods sales surging 586.4% year-over-year, supporting earnings resilience.
Bridgefront Capital LLC bought a new stake in Cal-Maine Foods, Inc. (NASDAQ: CALM) during the third quarter, according to its most recent disclosure with the SEC. The firm bought 7,366 shares of the basic materials company's stock, valued at approximately $693,000. Other hedge funds and other institutional investors have also recently bought and
Cal-Maine Foods, Inc. remains a Buy following its latest earnings, but technicals are broken and caution is warranted after a sharp collapse in wholesale egg prices. CALM's Q2 saw net sales down 19.4% and EPS down 52.3%, yet specialty eggs and prepared foods showed resilience and growth potential. CALM management highlights strategic diversification into specialty eggs and prepared foods, aiming for steadier, less cyclical earnings and double-digit growth in value-added segments.
Cal-Maine Foods, Inc. (CALM) Q2 2026 Earnings Call Transcript